Chris Rallis - Oct 20, 2022 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Chris A, Rallis
Stock symbol
FENC
Transactions as of
Oct 20, 2022
Transactions value $
-$12,082
Form type
4
Date filed
10/20/2022, 04:15 PM
Previous filing
Jul 18, 2022
Next filing
Nov 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Options Exercise $5K +4.76K +17.22% $1.05* 32.4K Oct 20, 2022 Direct F1
transaction FENC Common Shares Tax liability -$17.1K -2.07K -6.38% $8.26 30.4K Oct 20, 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents options granted on November 11, 2012, with a $1.05 USD strike price and an expiration of November 11, 2022.
F2 Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 4,762 shares from an November 11, 2012 grant.